tiprankstipranks
China Pharma Holdings (CPHI)
NYSE MKT:CPHI
US Market

China Pharma Holdings (CPHI) Stock Price & Analysis

246 Followers

CPHI Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.30 - $2.70
Previous Close$0.32
Volume137.09K
Average Volume (3M)449.96K
Market Cap
$4.71M
Enterprise Value$7.62M
Total Cash (Recent Filing)$1.37M
Total Debt (Recent Filing)$4.28M
Price to Earnings (P/E)-0.3
Beta0.95
May 16, 2024
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.00
Shares Outstanding14,816,865
10 Day Avg. Volume703,860
30 Day Avg. Volume449,959
Standard Deviation0.24
R-Squared0.04
Alpha-0.05
Financial Highlights & Ratios
Price to Book (P/B)1.05
Price to Sales (P/S)0.58
Price to Cash Flow (P/CF)1.20
P/FCF Ratio1.10
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.98
Enterprise Value/Gross Profit-15.43
Enterprise Value/Ebitda-217.56
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Risk Analysis

Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks

Website Traffic

Sorry, No Data Available
There is no website visitor data available for this stock.
---

CPHI FAQ

What was China Pharma Holdings’s price range in the past 12 months?
China Pharma Holdings lowest stock price was $0.30 and its highest was $2.69 in the past 12 months.
    What is China Pharma Holdings’s market cap?
    Currently, no data Available
    When is China Pharma Holdings’s upcoming earnings report date?
    China Pharma Holdings’s upcoming earnings report date is May 16, 2024 which is in 22 days.
      How were China Pharma Holdings’s earnings last quarter?
      China Pharma Holdings released its earnings results on Nov 17, 2023. The company reported -$0.059 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.059.
        Is China Pharma Holdings overvalued?
        According to Wall Street analysts China Pharma Holdings’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does China Pharma Holdings pay dividends?
          China Pharma Holdings does not currently pay dividends.
          What is China Pharma Holdings’s EPS estimate?
          China Pharma Holdings’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does China Pharma Holdings have?
          China Pharma Holdings has 14,816,865 shares outstanding.
            What happened to China Pharma Holdings’s price movement after its last earnings report?
            China Pharma Holdings reported an EPS of -$0.059 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -2.174%.
              Which hedge fund is a major shareholder of China Pharma Holdings?
              Currently, no hedge funds are holding shares in CPHI
              ---

              China Pharma Holdings Stock Smart Score

              N/A
              Not Ranked
              1
              2
              3
              4
              5
              6
              7
              8
              9
              10

              Technicals

              SMA
              Negative
              20 days / 200 days
              Momentum
              -82.38%
              12-Months-Change

              Fundamentals

              Return on Equity
              -52.43%
              Trailing 12-Months
              Asset Growth
              -7.39%
              Trailing 12-Months

              Company Description

              China Pharma Holdings

              China Pharma Holdings, Inc. engages in the development, manufacture, and marketing of pharmaceutical products. It caters people with cardiovascular, central nervous system, infectious, and digestive diseases. The company was founded by Zhi Lin Li on January 28, 1999 and is headquartered in Haikou, China.
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              Assertio Therapeutics
              Traws Pharma
              Bio-Path Holdings
              Popular Stocks
              ---
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis